GlassScriptPhysician profile
Noemi E Salang Ramsay
NPI 1508822735
$2,821.13
in general payments reported to CMS, 2019-2025
32 companies · $323 in 2025
The $323 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $272 · 2021: $390 · 2022: $295 · 2023: $240 · 2024: $517 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,087.39 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.27 | 2019-2025 | Relistor |
| Pacira Therapeutics, INC. | $185.53 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $161.98 | 2019-2025 | |
| Averitas Pharma INC. | $129.76 | 2024 | Qutenza |
| Mdd US Operations, LLC | $127.76 | 2019 | |
| Daiichi Sankyo INC. | $119.08 | 2019 | |
| Lilly USA, LLC | $88.06 | 2019-2021 | |
| Boston Scientific Corporation | $72.38 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $56.33 | 2020-2022 | |
| Pfizer INC. | $55.12 | 2019-2021 | |
| Zyla Life Sciences, INC. | $52.96 | 2019-2020 | |
| Amgen INC. | $43.42 | 2019 | |
| Biodelivery Sciences International, INC. | $38.93 | 2020-2021 | |
| Allergan, INC. | $34.70 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $34.20 | 2020-2022 | |
| Bioventus LLC | $32.62 | 2020-2021 | |
| Abbvie INC. | $31.77 | 2023-2024 | Botox |
| Stimwave Technologies Incorporated | $30.22 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $29.71 | 2019-2022 | |
| Redhill Biopharma INC. | $27.25 | 2021 | |
| Horizon Therapeutics Plc | $27.04 | 2021-2022 | |
| Medtronic, INC. | $19.67 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $18.04 | 2024 | |
| Sun Pharmaceutical Industries INC. | $17.78 | 2021 | |
| Kaleo, INC. | $17.73 | 2019 | |
| Shionogi INC | $17.22 | 2019 | |
| Grt US Holding, INC. | $16.84 | 2021 | |
| Globus Medical, INC. | $16.45 | 2025 | Vyrsa V1 |
| Astrazeneca Pharmaceuticals LP | $16.40 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.72 | 2019 | |
| Vgi Medical, LLC | $7.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noemi Salang Ramsay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.